SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-19-000031
Filing Date
2019-09-12
Accepted
2019-09-12 21:58:15
Documents
2
Period of Report
2019-09-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156833987897245.html 4  
1 FORM 4 wf-form4_156833987897245.xml 4 3966
2 POWER OF ATTORNEY FOR: /S/ WILLIAM K. MCVICAR poa.htm EX-24 4376
  Complete submission text file 0001615219-19-000031.txt   9866
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOTEK PHARMACEUTICALS CORPORATION 131 HARTWELL AVENUE, SUITE 105 LEXINGTON MA 02421
Business Address
McVicar William K. (Reporting) CIK: 0001634368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 191091470